<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04724148</url>
  </required_header>
  <id_info>
    <org_study_id>Fentanyl and HVPG</org_study_id>
    <nct_id>NCT04724148</nct_id>
  </id_info>
  <brief_title>Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension</brief_title>
  <official_title>Impact of Fentanyl Analgesia on the Accuracy of Hepatic Venous Pressure Gradient Measurements in Patients With Portal Hypertension：a Prospective, Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hepatopancreatobiliary Surgery Institute of Gansu Province</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lishui hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital, Zhejiang University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hepatopancreatobiliary Surgery Institute of Gansu Province</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Portal hypertension is a common complication of chronic liver disease and is associated with&#xD;
      most clinical consequences of cirrhosis. The most reliable method for assessing portal&#xD;
      hypertension is the measurement of the hepatic venous pressure gradient (HVPG). The HVPG is&#xD;
      the gold-standard methods for assessing clinically significant portal hypertension and&#xD;
      becoming increasingly used clinically. It is useful in the differential diagnosis of portal&#xD;
      hypertension and provides a prognostic index in cirrhotic patients. Many patients are painful&#xD;
      and reluctant to undergo serial HVPG measurements. But interventionists are reluctant to use&#xD;
      analgesics because they always pay more attention to the accuracy of HVPG&#xD;
      measurements.Although Adam F. et al concluded that low-dose midazolam sedation is an option&#xD;
      for patients undergoing serial hepatic venous pressure measurements (Hepatology 1999), the&#xD;
      effects of using opioid analgesics alone on hepatic venous pressure measurements have not yet&#xD;
      been defined. The objective of this study was to evaluate the effects of fentanyl on the&#xD;
      HVPG.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Portal hypertension is a common complication of chronic liver disease and is associated with&#xD;
      most clinical consequences of cirrhosis. The most reliable method for assessing portal&#xD;
      hypertension is the measurement of the hepatic venous pressure gradient (HVPG). The HVPG is&#xD;
      the gold-standard methods for assessing clinically significant portal hypertension and&#xD;
      becoming increasingly used clinically. It is useful in the differential diagnosis of portal&#xD;
      hypertension and provides a prognostic index in cirrhotic patients. Many patients are painful&#xD;
      and reluctant to undergo serial HVPG measurements. But interventionists are reluctant to use&#xD;
      analgesics because they always pay more attention to the accuracy of HVPG measurements. May&#xD;
      be since it is difficult to monitor HVPG for anesthesiologist during liver surgery, there are&#xD;
      very few and controversial studies on the effects of sedation and analgesics on HVPG. M.&#xD;
      Susan Mandell et al concluded that desflurane alters HVPG measurements, whereas propofol did&#xD;
      not change it (Anesth Analg 2003). However, Enric Reverter et al considered that deep&#xD;
      sedation with propofol and remifentanil adds substantial variability and uncertainty to HVPG&#xD;
      measurements (Liver International 2013). Although Adam F. et al concluded that low-dose&#xD;
      midazolam sedation is an option for patients undergoing serial hepatic venous pressure&#xD;
      measurements (Hepatology 1999), the effects of using opioid analgesics alone on hepatic&#xD;
      venous pressure measurements have not yet been defined. The objective of this study was to&#xD;
      evaluate the effects of fentanyl on the HVPG measurements.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 20, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of HVPG</measure>
    <time_frame>1~2 hours</time_frame>
    <description>To assess whether fentanyl would affect the accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">4</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Portal Hypertension</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Injecting 1~2mg/kg fentanyl intravenously.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Measuring HVPG after the preparation of TIPS in patients with portal hypertension;&#xD;
Measuring HVPG again 5 minutes later after injecting 1~2mg/kg fentanyl intravenously.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>To assess the accuracy of HVPG in TIPS after injecting a dose of 1~2 mg/kg fentanyl.</description>
    <arm_group_label>Injecting 1~2mg/kg fentanyl intravenously.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with cirrhosis and portal hypertension undergoing elective TIPS placement&#xD;
&#xD;
          -  ASAⅠ~Ⅲ&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with portal vein thrombosis and vein-to-vein communications&#xD;
&#xD;
          -  Refusal of consent&#xD;
&#xD;
          -  Presence of allergy to fentanyl&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaolong Qi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xun Li, MD</last_name>
    <role>Study Chair</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Haijun Zhang, MD</last_name>
    <role>Study Director</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lei Li, MD</last_name>
    <role>Study Director</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhongwei Zhao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lishui hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jiansong Ji, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lishui hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chuan guang Wang, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lishui hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wei Wu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lishui hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lili Yang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lishui hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yulan Li, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>YuJiang Yin</last_name>
    <role>Principal Investigator</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wei Yang, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital with Nanjing Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zi Niu Yu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital, Zhejiang University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wentao Wu, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital with Nanjing Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xujun Yang, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shuangxi Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fangyu Xu</last_name>
    <role>Principal Investigator</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Weizhong Zhou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital with Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaolong Qi, MD</last_name>
    <phone>+8618588602600</phone>
    <phone_ext>+8618588602600</phone_ext>
    <email>qixiaolong@vip.163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haijun Zhang, MD</last_name>
    <phone>+8618215160461</phone>
    <phone_ext>+8618215160461</phone_ext>
    <email>zhanghj19@lzu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Hospital of Lanzhou University</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>730000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Steinlauf AF, Garcia-Tsao G, Zakko MF, Dickey K, Gupta T, Groszmann RJ. Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology. 1999 Apr;29(4):1070-3.</citation>
    <PMID>10094948</PMID>
  </reference>
  <reference>
    <citation>Reverter E, Blasi A, Abraldes JG, Martínez-Palli G, Seijo S, Turon F, Berzigotti A, Balust J, Bosch J, García-Pagán JC. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int. 2014 Jan;34(1):16-25. doi: 10.1111/liv.12229. Epub 2013 Jun 13.</citation>
    <PMID>23763484</PMID>
  </reference>
  <reference>
    <citation>Mandell MS, Durham J, Kumpe D, Trotter JF, Everson GT, Niemann CU. The effects of desflurane and propofol on portosystemic pressure in patients with portal hypertension. Anesth Analg. 2003 Dec;97(6):1573-1577. doi: 10.1213/01.ANE.0000090741.63156.1B.</citation>
    <PMID>14633521</PMID>
  </reference>
  <reference>
    <citation>Chinese Portal Hypertension Diagnosis and Monitoring Study Group (CHESS); Minimally Invasive Intervention Collaborative Group, Chinese Society of Gastroenterology; Emergency Intervention Committee, Chinese College of Interventionalists; Hepatobiliary Diseases Collaborative Group, Chinese Society of Gastroenterology; Spleen and Portal Hypertension Group, Chinese Society of Surgery; Fatty Liver and Alcoholic Liver Disease Group, Chineses Society of Hepatology; Chinese Research Hospital Association for the Study of the Liver; Hepatobiliary and Pancreatic Diseases Prevention and Control Committee, Chinese Preventive Medicine Association; Chinese Society of Digital Medicine; Chinese Society of Clinical Epidemiology and Evidence Based Medicine. [Consensus on clinical application of hepatic venous pressure gradient in China (2018)]. Zhonghua Gan Zang Bing Za Zhi. 2018 Nov 20;26(11):801-812. doi: 10.3760/cma.j.issn.1007-3418.2018.11.001. Chinese.</citation>
    <PMID>30616313</PMID>
  </reference>
  <reference>
    <citation>Qi X, Berzigotti A, Cardenas A, Sarin SK. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018 Oct;3(10):708-719. doi: 10.1016/S2468-1253(18)30232-2. Review.</citation>
    <PMID>30215362</PMID>
  </reference>
  <reference>
    <citation>Qi X, An W, Liu F, Qi R, Wang L, Liu Y, Liu C, Xiang Y, Hui J, Liu Z, Qi X, Liu C, Peng B, Ding H, Yang Y, He X, Hou J, Tian J, Li Z. Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension. Radiology. 2019 Feb;290(2):370-377. doi: 10.1148/radiol.2018180425. Epub 2018 Nov 20.</citation>
    <PMID>30457484</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hepatopancreatobiliary Surgery Institute of Gansu Province</investigator_affiliation>
    <investigator_full_name>Xiaolong Qi</investigator_full_name>
    <investigator_title>Director, Institute of Portal Hypertension</investigator_title>
  </responsible_party>
  <keyword>hepatic venous pressure gradient</keyword>
  <keyword>fentanyl</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

